Treatment and Pre-meds Flashcards

1
Q

Tumors in upper 1/3 of rectum

A

Treat as colon cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tumers in lower 2/3 of rectum

A

Treat as rectal cancer- radiation is adjuvant therapy and palliative therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Stage 0-1

A

Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Stage 2

A

Surgery +/- adjuvant therapy (high-risk Duke Grade 3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Stage 3

A

Surgery + adjuvant therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stage 4

A

Chemotherapy +/- surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Adjuvant therapy

A

FOLFOX X 6 months= 5-FU, Leucovorin, Oxaliplatin
5-FU
Oxaliplatin: peripheral neuropathy is dose limiting and cold-induced–> avoid cold drinks and ice cream for 5 days. Can cause laryngeal spasm- cover up when going outdoors. Not renally toxic like cisplatin. Neutropenia (acute), peripheral neuropathy (cumulative), nausea and vomiting, mucositis, diarrhea, cold induced neuropathy/dysesthesias.
Give dexamethasone, granisetron, and aprepitant.
5-FU: Diarrhea, mucositis, myelosuppression, nausea and vomiting, HFS
Severe diarrhea: Loperamide 4 mg now, 2 mg q2hrs until diarrhea free for 12 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

First line chemotherapy for metastatic disease

A

FOLFOX/FOLFIRI/XELOX + mab.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Second line chemotherapy for metastatic disease

A

All regimens include 5-FU. Add another agent not previously given (OX or IRI). Consider giving mab or aflibercept.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Third line chemotherapy for metastatic disease

A

Cetuximab or panitumumab +/- ironotecan OR regorafanib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cetuximab and panitumumab

A

EGFR mabs
Can only be used in WT KRAS.
Skin rash, hypersensitivity reaction, electrolyte imbalance, diarrhea, mucositis, ILD (rare).
Infusion related reactions requiring discontinuation with cetuximab.
Give 50-100 mg doxycyline PO BID.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bevacizumab and Aflibercept

A

VEGF inhibitors

HTN, proteinuria, wound dehiscence, arterial thrombosis, hemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Regorafenib

A

VEGF TKI

Fatigue, hoarseness, HFS, HTN, diarrhea, rash, mucositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Capecitabine

A

HFS and hyperbilirubinemia seen, don’t really see it with continuous infusion 5-FU.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly